(2) Why did the landmark trials in 2015 succeed? Sub-group analyses and secondary results from IMS III trial indicated that there was a strong trend toward benefit of thrombectomy in patients with radiographically confirmed large vessel occlusion ( 12 ) (a key feature of the HERMES trials) and who achieved high-quality (mTICI 2b or (3) recanalization.
← all excerpts
Neurothrombectomy for Acute Ischemic Stroke Across Clinical Trial Design and Technique: A Single Center Pooled Analysis.
1
—
—